Tag:
Maxy-4
Latest Headlines
Latest Headlines
Astellas buys out Maxygen stake in JV for $76M
Astellas Pharma has exercised a buy-out option to acquire all of Maxygen's ownership interest in Perseid Therapeutics, a protein joint venture between the two companies. They formed the JV back in
Maxygen inks $180M deal with Astellas
Maxygen is pocketing a $10 million upfront fee from Japan's Astellas for marketing rights to its Maxy-4 therapies--a preclinical program focused on developing a next-generation CTLA4-Ig protein for
